Search details
1.
Experience of Subcutaneous Levetiracetam in Palliative Care.
Med Princ Pract
; 32(1): 90-95, 2023.
Article
in English
| MEDLINE | ID: mdl-36731437
2.
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma.
N Engl J Med
; 379(18): 1711-1721, 2018 Nov 01.
Article
in English
| MEDLINE | ID: mdl-30380386
3.
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015.
Breast Cancer Res Treat
; 181(3): 623-633, 2020 Jun.
Article
in English
| MEDLINE | ID: mdl-32378051
4.
Less Toxic Chemotherapy in Locally Advanced Breast Cancer.
South Med J
; 113(11): 559-563, 2020 11.
Article
in English
| MEDLINE | ID: mdl-33140109
5.
Impact of Guideline-Discordant Treatment on Cost and Health Care Utilization in Older Adults with Early-Stage Breast Cancer.
Oncologist
; 24(1): 31-37, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30120157
6.
Histone deacetylase inhibition promotes intratumoral CD8+ T-cell responses, sensitizing murine breast tumors to anti-PD1.
Cancer Immunol Immunother
; 68(12): 2081-2094, 2019 Dec.
Article
in English
| MEDLINE | ID: mdl-31720815
7.
The expression of MHC class II molecules on murine breast tumors delays T-cell exhaustion, expands the T-cell repertoire, and slows tumor growth.
Cancer Immunol Immunother
; 68(2): 175-188, 2019 Feb.
Article
in English
| MEDLINE | ID: mdl-30334128
8.
Concordance with NCCN treatment guidelines: Relations with health care utilization, cost, and mortality in breast cancer patients with secondary metastasis.
Cancer
; 124(21): 4231-4240, 2018 11 01.
Article
in English
| MEDLINE | ID: mdl-30317547
9.
The antitumor effects of entinostat in ovarian cancer require adaptive immunity.
Cancer
; 124(24): 4657-4666, 2018 12 15.
Article
in English
| MEDLINE | ID: mdl-30423192
10.
Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer.
Breast Cancer Res Treat
; 167(3): 731-740, 2018 02.
Article
in English
| MEDLINE | ID: mdl-29110152
11.
Impact of Nonconcordance With NCCN Guidelines on Resource Utilization, Cost, and Mortality in De Novo Metastatic Breast Cancer.
J Natl Compr Canc Netw
; 16(9): 1084-1091, 2018 09.
Article
in English
| MEDLINE | ID: mdl-30181420
12.
NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.
J Natl Compr Canc Netw
; 16(3): 245-254, 2018 Mar.
Article
in English
| MEDLINE | ID: mdl-29523663
13.
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 16(3): 310-320, 2018 Mar.
Article
in English
| MEDLINE | ID: mdl-29523670
14.
Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib.
Breast Cancer Res
; 19(1): 123, 2017 Nov 21.
Article
in English
| MEDLINE | ID: mdl-29162134
15.
ELASPIC web-server: proteome-wide structure-based prediction of mutation effects on protein stability and binding affinity.
Bioinformatics
; 32(10): 1589-91, 2016 05 15.
Article
in English
| MEDLINE | ID: mdl-26801957
16.
First-in-human study of the antibody DR5 agonist DS-8273a in patients with advanced solid tumors.
Invest New Drugs
; 35(3): 298-306, 2017 06.
Article
in English
| MEDLINE | ID: mdl-28050790
17.
Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 15(5): 608-638, 2017 05.
Article
in English
| MEDLINE | ID: mdl-28476741
18.
NCCN Guidelines Insights: Breast Cancer, Version 1.2017.
J Natl Compr Canc Netw
; 15(4): 433-451, 2017 04.
Article
in English
| MEDLINE | ID: mdl-28404755
19.
A phase 2 study of inotuzumab ozogamicin in patients with indolent B-cell non-Hodgkin lymphoma refractory to rituximab alone, rituximab and chemotherapy, or radioimmunotherapy.
Br J Haematol
; 174(4): 571-81, 2016 Aug.
Article
in English
| MEDLINE | ID: mdl-27101934
20.
A phase 1 study evaluating the safety and tolerability of otlertuzumab, an anti-CD37 mono-specific ADAPTIR therapeutic protein in chronic lymphocytic leukemia.
Blood
; 123(9): 1302-8, 2014 Feb 27.
Article
in English
| MEDLINE | ID: mdl-24381226